Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease
Authors:
- Hirohide AsaiHAHirohide Asai
- Fukashi UdakaFUFukashi Udaka
- Makito HiranoMHMakito Hirano
- Takeshi MinamiTMTakeshi Minami
- Masaya OdaMOMasaya Oda
- Tamotsu KuboriTKTamotsu Kubori
- Kazuto NishinakaKNKazuto Nishinaka
- Masakuni KameyamaMKMasakuni Kameyama
- Satoshi UenoSUSatoshi Ueno
- 1 December 2005
- journal article
- clinical trial
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 11 (8) , 499-502
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Safety and Tolerability of Tegaserod in Irritable Bowel Syndrome ManagementJournal of the American Pharmacists Association, 2004
- The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Early morning akinesia in Parkinson's diseaseNeurology, 1996
- Gastric emptying in Parkinson's diseaseNeurology, 1996
- Recent advances in gastric emptying scintigraphySeminars in Nuclear Medicine, 1995
- Effect of cisapride on response fluctuations in Parkinson's diseaseMovement Disorders, 1995
- Double‐blind, placebo‐controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on‐off' fluctuationsNeurology, 1993
- Erratic gastric emptying of levodopa may cause “random” fluctuations of parkinsonian mobilityNeurology, 1988
- Absorption and Metabolism of L‐Dopa by the Human StomachEuropean Journal of Clinical Investigation, 1971